{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:32:48Z","timestamp":1758774768481,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ygyno.2019.12.041","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T01:05:01Z","timestamp":1580432701000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disparities in care among patients with low-grade serous ovarian carcinoma"],"prefix":"10.1016","volume":"157","author":[{"given":"J.","family":"Siemon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schlumbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ygyno.2019.12.041_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0015","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3802\/jgo.2018.29.e15","article-title":"Trends of low-grade serous ovarian carcinoma in the United States","volume":"29","author":"Matsuo","year":"2018","journal-title":"J. Gynecol. Oncol."},{"author":"Cancer Stat Facts: Ovarian Cancer National Cancer Institute","key":"10.1016\/j.ygyno.2019.12.041_bb0020"},{"issue":"2","key":"10.1016\/j.ygyno.2019.12.041_bb0025","first-page":"247","article-title":"IV. Current status and future perspectives in low-grade serous cancer of the ovary","volume":"45","author":"Siemon","year":"2018","journal-title":"Gan To Kagaku Ryoho"},{"issue":"4","key":"10.1016\/j.ygyno.2019.12.041_bb0030","doi-asserted-by":"crossref","first-page":"459 e1","DOI":"10.1016\/j.ajog.2008.01.035","article-title":"Epidemiology of low-grade serous ovarian cancer","volume":"198","author":"Plaxe","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.12.041_bb0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2007.11.013","article-title":"Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum","volume":"108","author":"Schmeler","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2019.12.041_bb0040","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jso.25380","article-title":"Rare metastatic patterns after malignant transformation of serous borderline tumor of the ovary","volume":"119","author":"Siemon","year":"2019","journal-title":"J. Surg. Oncol."},{"year":"2018","series-title":"About the National Cancer Database","key":"10.1016\/j.ygyno.2019.12.041_bb0045"},{"issue":"11","key":"10.1016\/j.ygyno.2019.12.041_bb0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/djt065","article-title":"Disparities in ovarian cancer care quality and survival according to race and socioeconomic status","volume":"105","author":"Bristow","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.ygyno.2019.12.041_bb0055","first-page":"1261","article-title":"The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database","volume":"27","author":"Beckmeyer-Borowko","year":"2016","journal-title":"Cancer Causes Control"},{"year":"2004","series-title":"2004 HHS Poverty Guidelines","key":"10.1016\/j.ygyno.2019.12.041_bb0060"},{"year":"2015","series-title":"2015 Poverty Guidelines","key":"10.1016\/j.ygyno.2019.12.041_bb0065"},{"year":"2000","series-title":"P.;. Modeling Survival Data: Extending the Cox Model","author":"Therneau","key":"10.1016\/j.ygyno.2019.12.041_bb0070"},{"author":"Therneau","key":"10.1016\/j.ygyno.2019.12.041_bb0075"},{"year":"2019","series-title":"R: A Language and Environment for Statistical Computing","key":"10.1016\/j.ygyno.2019.12.041_bb0080"},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2017.07.127","article-title":"Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: reducing overtreatment without compromising survival?","volume":"147","author":"Fader","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2019.12.041_bb0095","first-page":"62","article-title":"Survival disparities among racial\/ethnic groups of women with ovarian T cancer: an update on data from the surveillance, epidemiology and end results (SEER) registry","author":"Stenzel","year":"2019","journal-title":"Cancer Epidemiol."},{"year":"2019","series-title":"SEER Cancer Statistics Review, 1975\u20132016","key":"10.1016\/j.ygyno.2019.12.041_bb0100"},{"issue":"2","key":"10.1016\/j.ygyno.2019.12.041_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.coc.0000199918.31226.f8","article-title":"Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival","volume":"29","author":"Stefanidis","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2019.12.041_bb0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/aje\/kwp176","article-title":"Ovarian cancer risk factors in African-American and white women","volume":"170","author":"Moorman","year":"2009","journal-title":"Am. J. Epidemiol."},{"year":"2010","series-title":"The Patient Protection and Affordable Care Act","key":"10.1016\/j.ygyno.2019.12.041_bb0115"},{"issue":"11","key":"10.1016\/j.ygyno.2019.12.041_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008152","article-title":"Not all insurance is equal: differential treatment and health outcomes by insurance coverage among nonelderly adult patients with heart attack","volume":"7","author":"Niedzwiecki","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ygyno.2019.12.041_bb0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1370\/afm.748","article-title":"Insurance + access not equal to health care: typology of barriers to health care access for low-income families","volume":"5","author":"Devoe","year":"2007","journal-title":"Ann. Fam. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2019.12.041_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjms.2019.05.005","article-title":"Trends in out-of-pocket burden in United States adults with kidney disease: 2002-2011","volume":"358","author":"Ozieh","year":"2019","journal-title":"Am J Med Sci"},{"issue":"20","key":"10.1016\/j.ygyno.2019.12.041_bb0135","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.30159","article-title":"Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors","volume":"122","author":"Markt","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.12.041_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/coa.13467","article-title":"Impact of insurance on survival in patients <65 with head & neck cancer treated with radiotherapy","volume":"45","author":"Sittig","year":"2019","journal-title":"Clin. Otolaryngol."},{"issue":"6","key":"10.1016\/j.ygyno.2019.12.041_bb0145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.21037\/jgo.2018.08.07","article-title":"Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis","volume":"9","author":"Ramey","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ygyno.2019.12.041_bb0150","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-019-07566-7","article-title":"Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: a National Cancer Database analysis","volume":"26","author":"Kupstas","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2019.12.041_bb0155","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cncr.29191","article-title":"Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database","volume":"121","author":"Murphy","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/AOG.0b013e31823d4006","article-title":"Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?","volume":"119","author":"Chase","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2019.12.041_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/AOG.0b013e31829ce7ec","article-title":"Survival in women with grade 1 serous ovarian carcinoma","volume":"122","author":"Fader","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.12.041_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2016.01.022","article-title":"Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase","volume":"140","author":"Grabowski","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2019.12.041_bb0175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7150\/jca.11242","article-title":"Prognostic significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"6","author":"Chen","year":"2015","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2019.12.041_bb0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.24801","article-title":"Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma","volume":"117","author":"Matsuo","year":"2018","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ijgc-2018-000018","article-title":"Low grade serous ovarian carcinoma: identifying variations in practice patterns","volume":"29","author":"Siemon","year":"2019","journal-title":"Int. J. Gynecol. Cancer Soc."},{"issue":"10","key":"10.1016\/j.ygyno.2019.12.041_bb0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.2016.71.0632","article-title":"Hormonal maintenance therapy for women with low-grade serous cancer of the ovary or peritoneum","volume":"35","author":"Gershenson","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.12.041_bb0195","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.ygyno.2019.12.041_bb0200","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e31803199b0","article-title":"Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma","volume":"31","author":"Malpica","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.12.041_bb0205","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/gyno.2000.5815","article-title":"National cancer data base\/surveillance epidemiology and end results: potential insensitive-measure bias","volume":"77","author":"Fanning","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2019.12.041_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1245\/s10434-009-0771-3","article-title":"The national cancer data base: past, present, and future","volume":"17","author":"Winchester","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.12.041_bb0215","first-page":"177","article-title":"Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies","volume":"18","author":"Clegg","year":"2007","journal-title":"Cancer Causes Control"},{"year":"2017","series-title":"National Cancer Data Base - Data Dictionary PUF 2015","key":"10.1016\/j.ygyno.2019.12.041_bb0220"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819318712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819318712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:52:17Z","timestamp":1758772337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819318712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0090825819318712"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.041","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in care among patients with low-grade serous ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}